Mannkind (MNKD) Cash from Investing Activities (2010 - 2026)

Mannkind (MNKD) reported Cash from Investing Activities of $18.7 million for Q1 2026, up 214.07% year-over-year from $6.0 million in Q1 2025, and up 106.41% quarter-over-quarter from -$292.0 million in Q4 2025.

Mannkind (MNKD) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Cash from Investing Activities data on file, last reported at $18.7 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $18.7 million, up 214.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$292.0 million (down 591.22% YoY), and the FY2025 annual result was -$304.8 million, down 215.37% from the prior year.
  • Cash from Investing Activities advanced to $18.7 million in Q1 2026 per MNKD's latest filing, from -$292.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $48.2 million in Q4 2024 and troughed at -$292.0 million in Q4 2025.
  • A 5-year average of -$22.3 million and a median of $2.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 710.82% in 2024 and fell as far as 1606.0% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $15.0 million in 2022, then slumped by 152.6% to -$7.9 million in 2023, then jumped by 710.82% to $48.2 million in 2024, then sank by 705.43% to -$292.0 million in 2025, then surged by 106.41% to $18.7 million in 2026.
  • Business Quant data shows MNKD's Cash from Investing Activities at $18.7 million in Q1 2026, -$292.0 million in Q4 2025, and -$25.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 18.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.73 Mn
Mar 31, 2026 18.73 Mn
Dec 31, 2025 -291.96 Mn
Dec 31, 2025 -291.96 Mn
Sep 30, 2025 -25.06 Mn
Sep 30, 2025 -25.06 Mn
Jun 30, 2025 6.26 Mn
Jun 30, 2025 6.26 Mn
Mar 31, 2025 5.96 Mn
Mar 31, 2025 5.96 Mn
Dec 31, 2024 48.22 Mn
Dec 31, 2024 48.22 Mn
Sep 30, 2024 -41.26 Mn
Sep 30, 2024 -41.26 Mn
Jun 30, 2024 -55.18 Mn
Jun 30, 2024 -55.18 Mn
Mar 31, 2024 -48.44 Mn
Mar 31, 2024 -48.44 Mn
Dec 31, 2023 -7.90 Mn
Dec 31, 2023 -7.90 Mn